CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to announce a collaboration with the Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). Together, the companies aim to make cancer treatments more affordable and accessible to all Americans. Through the relationship announced today, patients with a CureMatch report […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.